180 Life Sciences (180 Life Sciences) EV-to-EBITDA : 0.00 (As of Jun. 04, 2024)

View and export this data going back to 2017. Start your Free Trial

What is 180 Life Sciences EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, 180 Life Sciences's enterprise value is $0.00 Mil. 180 Life Sciences's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $-18.44 Mil. Therefore, 180 Life Sciences's EV-to-EBITDA for today is 0.00.

The historical rank and industry rank for 180 Life Sciences's EV-to-EBITDA or its related term are showing as below:

During the past 5 years, the highest EV-to-EBITDA of 180 Life Sciences was 1.76. The lowest was -47.72. And the median was 0.00.

ATNFW's EV-to-EBITDA is not ranked ^*
in the Biotechnology industry.
Industry Median: 9.47
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-04), 180 Life Sciences's stock price is $0.0097. 180 Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.000. Therefore, 180 Life Sciences's PE Ratio for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

180 Life Sciences EV-to-EBITDA Historical Data

The historical data trend for 180 Life Sciences's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

180 Life Sciences EV-to-EBITDA Chart

180 Life Sciences Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBITDA

-7.54

-6.31

-0.18

-0.06

180 Life Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBITDA	Get a 7-Day Free Trial															-0.11	-0.09	-0.04	-0.06	-0.11

Competitive Comparison of 180 Life Sciences's EV-to-EBITDA

For the Biotechnology subindustry, 180 Life Sciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

180 Life Sciences's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 180 Life Sciences's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where 180 Life Sciences's EV-to-EBITDA falls into.

180 Life Sciences EV-to-EBITDA Calculation

180 Life Sciences's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	0.000	/	-18.435
	=	0.00

180 Life Sciences's current Enterprise Value is $0.00 Mil.
180 Life Sciences's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-18.44 Mil.

180 Life Sciences (NAS:ATNFW) EV-to-EBITDA Explanation

180 Life Sciences's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.0097	/	0.000
	=	N/A

180 Life Sciences's share price for today is $0.0097.
180 Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

180 Life Sciences EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of 180 Life Sciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

180 Life Sciences (180 Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 180 Life Sciences Corp (NAS:ATNFW) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

ATNF:USA

Address

3000 El Camino Real, Bldg. 4, Suite 200, Palo Alto, CA, USA, 94306

Website

https://www.180lifesciences.com

180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics.